OOIR: Observatory of International Research

Papers

(The H4-Index of European Journal of Pharmaceutics and Biopharmaceutics is 37. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Microneedle array systems for long-acting drug delivery	176
Versatility of hydrogel-forming microneedles in in vitro transdermal delivery of tuberculosis drugs	93
Freeze-drying of nanoparticles: How to overcome colloidal instability by formulation and process optimization	92
Design of experiments (DoE) to develop and to optimize nanoparticles as drug delivery systems	81
Recent developments in stimuli-responsive polymer nanogels for drug delivery and diagnostics: A review	70
Biomimetic platelet membrane-coated nanoparticles for targeted therapy	69
Targeted rod-shaped mesoporous silica nanoparticles for the co-delivery of camptothecin and survivin shRNA in to colon adenocarcinoma in vitro and in vivo	66
Cisplatin-induced ototoxicity: Updates on molecular mechanisms and otoprotective strategies	65
3D-Printing with precise layer-wise dose adjustments for paediatric use via pressure-assisted microsyringe printing	65
Exosome-loaded hydrogels: A new cell-free therapeutic approach for skin regeneration	64
Etravirine-loaded dissolving microneedle arrays for long-acting delivery	63
Oral inhalation for delivery of proteins and peptides to the lungs	62
Combinatorial lipid-nanosystem for dermal delivery of 5-fluorouracil and resveratrol against skin cancer: Delineation of improved dermatokinetics and epidermal drug deposition enhancement analysis	60
Evolution of drug-eluting biomedical implants for sustained drug delivery	56
Trends in drug- and vaccine-based dissolvable microneedle materials and methods of fabrication	54
Treatment of acute lung inflammation by pulmonary delivery of anti-TNF-α siRNA with PAMAM dendrimers in a murine model	52
Long-acting nanoparticle-loaded bilayer microneedles for protein delivery to the posterior segment of the eye	52
Recent update of toxicity aspects of nanoparticulate systems for drug delivery	50
Design, fabrication, and characterisation of a silicon microneedle array for transdermal therapeutic delivery using a single step wet etch process	49
Recent advances in prodrug-based nanoparticle therapeutics	49
An integrated computational methodology with data-driven machine learning, molecular modeling and PBPK modeling to accelerate solid dispersion formulation design	46
Enhanced efficacy and drug delivery with lipid coated mesoporous silica nanoparticles in cancer therapy	45
Design, development and in-vitro/in-vivo evaluation of intranasally delivered Rivastigmine and N-Acetyl Cysteine loaded bifunctional niosomes for applications in combinative treatment of Alzheimer’s d	45
In situ gelling drug delivery systems for topical drug delivery	45
Binder jetting 3D printing of challenging medicines: From low dose tablets to hydrophobic molecules	44

Applications of nanotechnology in 3D printed tissue engineering scaffolds	44
Next-generation contact lenses: Towards bioresponsive drug delivery and smart technologies in ocular therapeutics	44
Lactoferrin-loaded nanostructured lipid carriers (NLCs) as a new formulation for optimized ocular drug delivery	43
Etoposide and olaparib polymer-coated nanoparticles within a bioadhesive sprayable hydrogel for post-surgical localised delivery to brain tumours	43
Physical formulation approaches for improving aqueous solubility and bioavailability of ellagic acid: A review	42
Improved multidetector asymmetrical-flow field-flow fractionation method for particle sizing and concentration measurements of lipid-based nanocarriers for RNA delivery	42
Synergistic activity of phage PEV20-ciprofloxacin combination powder formulation—A proof-of-principle study in a P. aeruginosa lung infection model	42
An overview of gastrointestinal mucus rheology under different pH conditions and introduction to pH-dependent rheological interactions with PLGA and chitosan nanoparticles	40
Design of experiments and design space approaches in the pharmaceutical bioprocess optimization	39
Impact of formulation on the quality and stability of freeze-dried nanoparticles	38
Hydroxypropyl methylcellulose acetate succinate as an exceptional polymer for amorphous solid dispersion formulations: A review from bench to clinic	37
Kidney-targeted astaxanthin natural antioxidant nanosystem for diabetic nephropathy therapy	37
Fasted and fed state human duodenal fluids: Characterization, drug solubility, and comparison to simulated fluids and with human bioavailability	37
Air-liquid interface (ALI) impact on different respiratory cell cultures	37